Animal models of steatohepatitis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 5, 2002, Pages 679-690

  Koteish, Ayman ^a   Diehl, Anna Mae ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

(TNF ); Inhibitor kappa kinase beta (IKK ); Insulin resistance; Oxidative stress; Tumour necrosis factor alpha

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIOXIDANT; CHOLINE; CYTOKINE; INSULIN; LEPTIN; METFORMIN; METHIONINE; OXIDIZING AGENT; PHOSPHOTRANSFERASE; PROBIOTIC AGENT; PROKINETIC AGENT; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; CASPASE 3; GLUTATHIONE; HYDROGEN PEROXIDE; I KAPPA B KINASE INHIBITOR; MANGANESE SUPEROXIDE DISMUTASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR 1; FATTY ACID;

CELL DEATH; DIABETES MELLITUS; DIET THERAPY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; EXERCISE; FATTY LIVER; HEPATITIS; HYPOTHESIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOATROPHY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN DEFICIENCY; PROTEIN RESTRICTION; RAT; REVIEW; VITAMIN DEFICIENCY; WEIGHT REDUCTION; ALCOHOL CONSUMPTION; ANIMAL MODEL; BACTERIAL OVERGROWTH; DIET; DRUG INHIBITION; DYSLIPIDEMIA; ENTEROPATHY; HISTOPATHOLOGY; IRON OVERLOAD; LIPODYSTROPHY; NONALCOHOLIC FATTY LIVER; TH1 CELL; ANIMAL; GENETICS; METABOLISM; MOUSE MUTANT; OXIDATION REDUCTION REACTION; TRANSGENIC MOUSE; ZUCKER RAT;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATTY ACIDS; FATTY LIVER; INSULIN RESISTANCE; LEPTIN; MICE; MICE, OBESE; MICE, TRANSGENIC; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, ZUCKER;

EID: 0036782608     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0332     Document Type: Article

References (62)

1. Marchesini G Forlani G From liver disease to metabolic disorders and back to clinical hepatology Hepatology 35 2002 497-499
2. Koteish A Diehl A M Animal models of steatosis Seminars in Liver Disease 21 2001 89-104
3. Friedman J M Leibel R Siegel D S et al. Molecular mapping of the mouse ob mutation Genetics 11 1991 1054-1062
4. Campfield L A Smith F J Burn P The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks Hormones and Metabolism Research 28 1996 619-632
5. Rosenbaum M Leibel R L Hirsch J Obesity New England Journal of Medicine 337 1997 396-407
6. Yang S Q Lin H Z Lane M D et al. Obesity increases sensitivity to endotoxin liver injury: implications for pathogenesis of steatohepatitis Proceedings of the National Academy of Science of the USA 94 1997 2557-2562
7. Chavin K Yang S Q Lin H Z et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion Journal of Biological Chemistry 274 1999 5692-5700
8. Day C P James O Steatohepatitis: a tale of two 'hits'? Gastroenterology 114 1998 842-845
9. Yang S Q Zhu H Li Y et al. Mitochondrial adaptations to obesity-related oxidant stress Archives of Biochemistry and Biophysics 378 2000 259-268
10. Yang S Q Lin H Z Diehl A M Fatty liver vulnerability to lipopolysaccharide despite NF-kB induction and caspase 3 inhibition American Journal of Physiology 281 2001 G382-G392
11. Yuan M Konstantopoulos N Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ Science 293 2001 1673-1677
12. Kim J K Kim Y J Fillmore J J et al. Prevention of fat-induced insulin resistance by salicylate Journal of Clinical Investigation 108 2001 437-446
13. Uysal K T Wiesbrock S M Marino M W Hotamisligil G S Protection from obesity-induced insulin-resistance in mice lacking TNF alpha function Nature 389 1997 610-614
14. Marchesini G Brizi M Morselli-Labate A M et al. Association of nonalcoholic fatty liver disease with insulin resistance American Journal of Medicine 107 1999 450-455
15. Yin M Wheeler M D Kono H et al. Essential role of tumour necrosis factor alpha in alcohol-induced liver injury in mice Gastroenterology 117 1999 942-952
16. Ludwig J Viggiano R T McGill D B Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease Mayo Clinic Proceedings 55 1980 342-348
17. Memon R A Grunfeld C Feingold K R Increased hepatic TNF alpha expression is not the cause for fatty liver disease in obese diabetic mice Nature Medicine 7 2001 2-3
18. Solomon S S Mishra S K Cwik C et al. Pioglitazone and metformin reverse insulin resistance induced by tumour necrosis factor-alpha in liver cells Hormones and Metabolism Research 29 1997 379-382
19. Lin H Z Yang S Q Kujhada F et al. Metformin reverses nonalcoholic fatty liver disease in obese leptin-deficient mice Nature Medicine 6 2000 998-1003
20. Tracey K J Cerami A Tumour necrosis factor, other cytokines and disease Annual Review of Cell Biology 9 1993 317-343
21. Rashid A Wu T-C Huang C C et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver Hepatology 29 1999 1131-1138
22. Jaeschke H Fisher M A Lawson J A et al. Activation of caspase 3 (CPP32)-like proteases is essential for TNF alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxic shock model Journal of Immunology 160 1998 3480-3486
23. Diehl A M Hoek J B Mitochondrial uncoupling: role of uncoupling protein anion carriers and relationship to thermogenesis and weight control Journal of Bioenergetics and Biomembranes 31 1999 493-506
24. Tilg H Diehl A M Cytokines in alcoholic and nonalcoholic steatohepatitis New England Journal of Medicine 343 2000 1467-1476
25. Yang S Q Lin H Z Mandal A K et al. Disrupted signaling and inhibition of liver regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathogenesis Hepatology 34 2001 694-706
26. Loffreda S Yang S Q Lin H Z et al. Leptin regulates proinflammatory immune responses FASEB Journal 12 1998 57-65
27. Lord G M Matarese G Howard J K et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394 1998 897-901
28. Guebre-Xabier M Yang S Q Lin H Z et al. Altered hepatic lymphocyte subpopulations in obesity-related fatty livers Hepatology 31 1999 633-640
29. Faggioni R Fantuzzi G Gabay C et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality American Journal of Physiology 276 1999 R136-R142
30. Diehl A M Cytokine regulation of liver injury and repair Immunology Reviews 174 2000 160-171
31. Fromenty B Pessayre D Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines Journal of Hepatology 26 1997 43-53
32. Nanji A A Khettry U Sadrzadeh S M Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease Proceedings of the Society for Experimental Biology and Medicine 205 1994 243-247
33. Adachi Y Moore L E Bradford B U et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 1995 218-224
34. Cope K Risby T Diehl A M Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis Gastroenterology 119 2000 1340-1347
35. Reitman M L Mason M M Moitra J et al. Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes Annals of the New York Academy of Sciences 1999 289-296
36. Shimomura I Hammer R E Richardson J A et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREP-1c in adipose tissue: model for congenital generalized lipodystrophy Genes and Development 12 1998 3182-3194s
37. Moitra J Mason M M Olive M et al. Life without white fat: a transgenic mouse Genes and Development 12 1998 3168-3181
38. Shimano H Horton J D Hammer R E et al. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a Journal of Clinical Investigation 98 1996 1575-1584
39. Shimomura I Hammer R E Ikemoto S et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 1999 73-76
40. Ghoshal A K Ahluwalia M Farber E The rapid induction of liver cell death in rats fed a choline-deficient methionine-low diet American Journal of Pathology 113 1983 309-314
41. Hensley K Kotake Y Sang H et al. Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria Carcinogenesis 21 2001 983-989
42. Newberne P M Effect of two synthetic antioxidants, vitamin E and ascorbic acid, on the choline-deficient rat Journal of Nutrition 97 1969 219-231
43. Leclerq I A Farrell G C Leptin is required for the development of hepatic fibrosis Hepatology 32 2000 302 (Abstract)
44. Wanless I R Lentz J S Fatty liver hepatitis (steatohepatitis) and obesity: an autospy study with analysis of risk factors Hepatology 12 1990 1106-1110
45. Potter J J Womack L Mezey E Anania F A Transdifferentiation of rat hepatic stellate cells results in leptin expression Biochemical and Biophysical Research Communications 244 1998 178-182
46. Frank S Stallmeyer B Kampfer H et al. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair Journal of Clinical Investigation 106 2000 501-509
47. Haines N W Baker A L Boyer J L et al. Prognostic indications of hepatic injury following jejunal ileal bypass for refractory obesity: a prospective study Hepatology 1 1981 161-165
48. Halverson J D Wise L Wazna M F et al. Jejunoileal bypass for morbid obesity: a critical appraisal American Journal of Medicine 64 1978 461-467
49. Requarth J A Burchard K W Colacchio T A et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal Archives of Surgery 130 1995 318-325
50. Heimburger S L Seiger E Logerfo P et al. Reversal of severe fatty hepatic infiltration after jejunoileal bypass for morbid obesity by calorie-free amino acid infusion American Journal of Surgery 129 1975 70-78
51. Hodgson M Van Thiel D H Goodman-Klein B Obesity and hepatotoxin risk factors for fatty liver disease British Journal of Industrial Medicine 48 1991 690-695
52. Naveau S Giraud V Borotto E et al. Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108-111
53. Marchesini G Brizl M Bianchi G et al. Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893-894
54. Caldwell S H Hespenheide E E Redick J A et al. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis American Journal of Gastroenterology 96 2001 519-525
55. Lavine J E Vitamin E treatment of non-alcoholic steatohepatitis in children: a pilot study Journal of Pediatrics 136 2000 734-738
56. Abdelmalek M F Angulo P Jorgensen R A et al. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study American Journal of Gastroenterology 96 2001 2711-2717
57. Diabetes Prevention Program Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346 2002 393-403
58. Palmer M Schaffner F Effect of weight reduction on hepatic abnormalities in overweight patients Gastroenterology 99 1990 1408-1411
59. Capron J P Delamarre M Dupas J L et al. Fasting in obesity: another cause of liver injury with alcoholic hyaline? Digestive Diseases and Sciences 54 1982 374-377
60. Karpe F Wejke J Anggard E Dietary arachidonic acid protects mice against the fatty liver induced by a high fat diet and by ethanol Acta Pharmacologica et Toxicologica 55 1984 95-99
61. Poulsom R Morphological changes of organs after sucrose or fructose feeding Progress in Biochemical Pharmacology 21 1986 104-134
62. Novikoff P M Fatty liver induced in Zucker 'fatty' (ff) rats by a semisynthetic diet rich in sucrose Proceedings of the National Academy of Sciences of the USA 74 1977 3550-3554